1. Home
  2. MBBC vs SABS Comparison

MBBC vs SABS Comparison

Compare MBBC & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBBC
  • SABS
  • Stock Information
  • Founded
  • MBBC 1902
  • SABS 2014
  • Country
  • MBBC United States
  • SABS United States
  • Employees
  • MBBC N/A
  • SABS N/A
  • Industry
  • MBBC Banks
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBBC Finance
  • SABS Health Care
  • Exchange
  • MBBC Nasdaq
  • SABS Nasdaq
  • Market Cap
  • MBBC 31.7M
  • SABS 31.2M
  • IPO Year
  • MBBC N/A
  • SABS N/A
  • Fundamental
  • Price
  • MBBC $11.48
  • SABS $4.09
  • Analyst Decision
  • MBBC
  • SABS Strong Buy
  • Analyst Count
  • MBBC 0
  • SABS 3
  • Target Price
  • MBBC N/A
  • SABS $9.00
  • AVG Volume (30 Days)
  • MBBC 5.6K
  • SABS 203.1K
  • Earning Date
  • MBBC 11-12-2025
  • SABS 11-13-2025
  • Dividend Yield
  • MBBC N/A
  • SABS N/A
  • EPS Growth
  • MBBC N/A
  • SABS N/A
  • EPS
  • MBBC 0.11
  • SABS N/A
  • Revenue
  • MBBC $7,299,708.00
  • SABS $114,698.00
  • Revenue This Year
  • MBBC N/A
  • SABS N/A
  • Revenue Next Year
  • MBBC N/A
  • SABS N/A
  • P/E Ratio
  • MBBC $102.67
  • SABS N/A
  • Revenue Growth
  • MBBC 7.77
  • SABS N/A
  • 52 Week Low
  • MBBC $7.21
  • SABS $1.00
  • 52 Week High
  • MBBC $12.89
  • SABS $6.60
  • Technical
  • Relative Strength Index (RSI)
  • MBBC 62.24
  • SABS 71.11
  • Support Level
  • MBBC $11.35
  • SABS $3.68
  • Resistance Level
  • MBBC $11.70
  • SABS $4.15
  • Average True Range (ATR)
  • MBBC 0.18
  • SABS 0.31
  • MACD
  • MBBC 0.06
  • SABS 0.04
  • Stochastic Oscillator
  • MBBC 60.97
  • SABS 93.18

About MBBC Marathon Bancorp Inc. Common Stock

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: